Phase I clinical and pharmacokinetic trial of oral menogaril administered on three consecutive days
- 1 June 1988
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 24 (6) , 1019-1026
- https://doi.org/10.1016/0277-5379(88)90152-6
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- A phase I study of menogaril in patients with advanced cancer.Journal of Clinical Oncology, 1987
- PHASE-I TRIAL OF MENOGARIL ADMINISTERED AS AN INTERMITTENT DAILY INFUSION FOR 5 DAYS1986
- Phase I study of intravenous menogaril administered intermittently.Journal of Clinical Oncology, 1986
- PHASE-I CLINICAL INVESTIGATION OF 7-CON-O-METHYLNOGARIL, A NEW ANTHRACYCLINE ANTIBIOTIC1986
- HUMAN PHARMACOKINETICS, EXCRETION, AND METABOLISM OF THE ANTHRACYCLINE ANTIBIOTIC MENOGARIL (7-OMEN, NSC 269148) AND THEIR CORRELATION WITH CLINICAL TOXICITIES1986
- Phase I study of oral idarubicin given with a weekly scheduleInvestigational New Drugs, 1986
- Quantitation of anthracycline antitumor agent menogarol in plasma using liquid chromatography with fluorescence detectionAnalytical Chemistry, 1984
- Reduction of Doxorubicin Cardiotoxicity by Prolonged Continuous Intravenous InfusionAnnals of Internal Medicine, 1982
- Mlab — A mathematical modeling toolComputer Programs in Biomedicine, 1979